Moxifloxacin/nepafenac/prednisolone ophthalmic Interactions
There are 114 drugs known to interact with moxifloxacin/nepafenac/prednisolone ophthalmic, along with 3 disease interactions. Of the total drug interactions, 1 is major, 112 are moderate, and 1 is minor.
- View all 114 medications that may interact with moxifloxacin/nepafenac/prednisolone ophthalmic
- View moxifloxacin/nepafenac/prednisolone ophthalmic disease interactions (3)
Most frequently checked interactions
View interaction reports for moxifloxacin / nepafenac / prednisolone ophthalmic and the medicines listed below.
- Advil (ibuprofen)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Allegra (fexofenadine)
- Azithromycin Dose Pack (azithromycin)
- B Complex 100 (multivitamin)
- Benadryl (diphenhydramine)
- Bystolic (nebivolol)
- Centrum Silver Men's (multivitamin with minerals)
- Centrum Silver Women's (multivitamin with minerals)
- Cimzia (certolizumab)
- Citrucel (methylcellulose)
- Claritin (loratadine)
- Clinpro 5000 (fluoride topical)
- Colace (docusate)
- CoQ10 (ubiquinone)
- Dulcolax (bisacodyl)
- Evenity (romosozumab)
- Flomax (tamsulosin)
- Flonase (fluticasone nasal)
- Flonase Sensimist (fluticasone nasal)
- Gaviscon Regular Strength Tablets (aluminum hydroxide / magnesium trisilicate)
- Gemtesa (vibegron)
- Hydromet (homatropine / hydrocodone)
- Imodium (loperamide)
- Iron Sulfate (ferrous sulfate)
- Kenalog-40 (triamcinolone)
- Levemir (insulin detemir)
- Metamucil (psyllium)
- MiraLAX (polyethylene glycol 3350)
- Paxlovid (nirmatrelvir / ritonavir)
Moxifloxacin/nepafenac/prednisolone ophthalmic disease interactions
There are 3 disease interactions with moxifloxacin / nepafenac / prednisolone ophthalmic which include:
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.